Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00743990 · ClinicalTrials.gov registry record · NA
Effect of Effect of a Medicated Topical Therapy , Petrolatum, and No Treatment on Nocturnal Cough
A NA study, sponsored by Penn State University.
- Completed
- Registry status
- NA
- Development phase
- 143
- Enrollment target
NCT00743990: Completed NA study, sponsored by Penn State University.
NCT00743990 is a NA study that has completed, run by Penn State University. The registered enrollment target is 143 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00743990, a NA study, has completed, sponsored by Penn State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 143 participants
- Enrollment target
Study Summary
This study seeks to subjectively evaluate whether a single application of Vicks® VapoRub® (VVR) ointment or a control ointment (petrolatum) will be superior to no treatment for control of nocturnal cough and congestion due to upper respiratory tract infection (URI) as rated by both parents and children.
Interventions
- OTHER Ointment containing camphor, eucalyptus oil, and menthol
- OTHER Petroleum jelly
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 143 participants |
| Start Date | 2008-10 |
| Est. Completion | 2010-03 |
| Phase | NA |
What the finished NCT00743990 record still lists
NCT00743990 is an interventional study that assigns participants to a tested intervention. The registered 143 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower).
The record links to 0 conditions, and to 2 interventions - of which Ointment containing camphor, eucalyptus oil, and menthol is the first listed.
NCT00743990 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00743990 about?
NCT00743990 is a clinical study titled "Effect of Effect of a Medicated Topical Therapy , Petrolatum, and No Treatment on Nocturnal Cough". This study seeks to subjectively evaluate whether a single application of Vicks® VapoRub® (VVR) ointment or a control ointment (petrolatum) will be superior to no treatment for control of nocturnal cough and congestion due to upper respiratory tract infection (URI) as rated by both parents and child...
What is the current status of trial NCT00743990?
This trial is currently completed. It is a NA study. The enrollment target is 143 participants. The study started on 2008-10. Estimated completion is 2010-03.
What interventions are being tested in trial NCT00743990?
The interventions under investigation include: Ointment containing camphor, eucalyptus oil, and menthol (OTHER), Petroleum jelly (OTHER).
Who is sponsoring clinical trial NCT00743990?
This trial is sponsored by Penn State University, which has 219 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00743990's enrollment target sits among peer trials
143 711th of 2000 higher than 1,290 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01861106 · 144 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations
- NCT03482245 · 144 participants · NA
The Role of Circadian Clock Proteins in Innate and Adaptive Immunity
- NCT03504683 · 144 participants · NA
MEAL TIMING Study: Effect of Time-Restricted Feeding on 24-hour Glycemic Control, Blood Pressure, and Cardiovascular Disease Risk Factors in Adults With Prediabetes
- NCT03905603 · 144 participants · Early Phase 1
Relative Contributions of Predictors of Hyperandrogenism in Older vs. Young Women With PCOS
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia